港股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

荃信生物-B

16.880

-0.090-0.53%

成交量：8,200

成交额：13.75万

市值：37.64亿

市盈率：10.27

高：17.000

开：16.970

低：16.530

收：16.970

52周最高：36.500

52周最低：13.210

股本：2.23亿

香港流通股本：2.23亿

量比：0.05

换手率：0.00%

股息：- -

股息率：- -

每股收益(LYR):1.644

净资产收益率：101.58%

总资产收益率：22.97%

市净率：3.75

市盈率(LYR):10.27

市销率: 3.15

数据加载中...

总览公司新闻资讯公告

自免龙头兑现长期主义：荃信生物（02509）营收翻倍背后的“双引擎”逻辑

荃信生物-B(02509)发布中期业绩股东应占溢利2.03亿元同比扭亏为盈 “荃信1.0”布局已基本成型

荃信生物-B（02509）2026年中期收入4.24亿元由亏转盈录得1.99亿元净利润

荃信生物-B（02509）拟于8月19日召开董事会审议2026年中期业绩

荃信生物-B发布7月股份变动月报，股本维持227,071,600元

荃信生物(02509.HK)QX027N获慢性阻塞性肺疾病及慢性鼻窦炎伴鼻息肉适应症临床试验默示许可

阿斯达克财经

荃信生物：QX027N注射液两项适应症获临床试验许可

荃信生物-B（02509）长效双抗QX027N获COPD及CRSwNP临床试验默示许可

荃信生物-B（02509.HK）旗下QX027n获两项临床试验批件，剑指COPD与慢性鼻窦炎

荃信生物-B(02509.HK)：QX027N获得慢性阻塞性肺疾病及慢性鼻窦炎伴鼻息肉两项适应症的临床试验默示许可

荃信生物-B(02509)合作伙伴Caldera Therapeutics拟与Synlogic合并登陆纳斯达克并同步募资 2.78 亿美元

荃信生物-B：合作方Caldera擬與Synlogic合併赴美上市並獲2.78億美元私募支持

荃信生物-B回购1000股股份，耗资约1.60万港元

荃信生物-B(02509)7月17日耗资约1.6万港元回购1000股

荃信生物－Ｂ(02509)股价下跌5.031%，现价港币$15.1

阿斯达克财经

荃信生物-B回购3,000股，耗资约4.52万港元

荃信生物-B(02509)7月9日斥资约4.52万港元回购3000股

荃信生物－Ｂ(02509)股价下跌5.35%，现价港币$14.86

阿斯达克财经

荃信生物-B：7月8日回购600股，耗资约9,420港元

荃信生物-B：7月7日回购8000股，耗资约12.56万港元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/02509/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02509","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"荃信生物-B","latestPrice":16.88,"timestamp":1787558159190,"preClose":16.97,"halted":0,"volume":8200,"delay":0,"changeRate":-0.005303476723629927,"floatShares":223000000,"shares":223000000,"eps":1.6438250368327012,"marketStatus":"未开盘","change":-0.09,"latestTime":"08-24 15:55:59","open":16.97,"high":17,"low":16.53,"amount":137538,"amplitude":0.027696,"askPrice":17.13,"askSize":1000,"bidPrice":16.8,"bidSize":7200,"shortable":3,"etf":0,"ttmEps":2.8116834488338927,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787621400000},"marketStatusCode":0,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":16.97,"openAndCloseTimeList":[[1787535000000,1787544000000],[1787547600000,1787558400000]],"volumeRatio":0.05209656924700785,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02509\",,,,,undefined,":{"symbol":"02509","floatShares":223000000,"roa":"22.97%","roe":"101.58%","lyrEps":1.643825,"volumeRatio":0.05209656924700785,"shares":223000000,"dividePrice":0,"high":17,"amplitude":0.027696,"preClose":16.97,"low":16.53,"week52Low":13.21,"pbRate":"3.75","psRate":"3.15","week52High":36.5,"institutionHeld":0,"latestPrice":16.88,"committee":0.756098,"eps":1.6438250368327012,"divideRate":0,"volume":8200,"delay":0,"ttmEps":2.8116834488338927,"open":16.97,"prevYearClose":18.78,"prevWeekClose":16.97,"prevMonthClose":16.3,"prevQuarterClose":14.18,"fiveDayClose":17.95,"twentyDayClose":16.2,"sixtyDayClose":16.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02509\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787103000000,"name":null,"time":"","dateTimestamp":1787068800000,"actualEps":null},{"date":"2026-03-27","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-03-28","symbol":"02509","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"盘后","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-15","symbol":"02509","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723685400000,"name":null,"time":"","dateTimestamp":1723651200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02509\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02509\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1769184000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02509\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02509","date":"2026-08-21","current":6.003877,"percent":0.839798,"low":-38.274716,"twenty":-20.041187,"median":-9.088801,"eighty":-3.461369,"high":13.150203,"avg":-9.116415,"sd":11.537008,"marketCap":3790626234},"quantilePoints":[{"date":"2024-03-22","current":-9.005941,"twenty":-9.920087,"median":-9.005941,"eighty":-8.797979,"marketCap":4652400020},{"date":"2024-03-28","current":-9.367246,"twenty":-9.484937,"median":-9.005941,"eighty":-8.416995,"marketCap":4821843660},{"date":"2024-04-05","current":-8.872714,"twenty":-9.396669,"median":-8.977885,"eighty":-8.598751,"marketCap":4565907160},{"date":"2024-04-12","current":-9.165919,"twenty":-9.386227,"median":-9.126184,"eighty":-8.830039,"marketCap":4719469060},{"date":"2024-04-19","current":-9.074252,"twenty":-9.304842,"median":-9.125412,"eighty":-8.934406,"marketCap":4668281760},{"date":"2024-04-26","current":-9.882424,"twenty":-9.513374,"median":-9.232059,"eighty":-8.994719,"marketCap":5077780160},{"date":"2024-05-03","current":-10.208268,"twenty":-9.517937,"median":-9.234052,"eighty":-9.046928,"marketCap":5241579520},{"date":"2024-05-10","current":-10.950727,"twenty":-10.058378,"median":-9.328243,"eighty":-9.081967,"marketCap":6018140360},{"date":"2024-05-17","current":-11.513141,"twenty":-10.522167,"median":-9.424295,"eighty":-9.09098,"marketCap":6317937020},{"date":"2024-05-24","current":-11.397533,"twenty":-11.287555,"median":-9.513128,"eighty":-9.098359,"marketCap":6240211960},{"date":"2024-05-31","current":-10.960491,"twenty":-11.380385,"median":-9.702863,"eighty":-9.110289,"marketCap":6007036780},{"date":"2024-06-07","current":-9.736726,"twenty":-11.329803,"median":-9.882424,"eighty":-9.125257,"marketCap":5329718400},{"date":"2024-06-14","current":-9.786262,"twenty":-11.239813,"median":-9.736726,"eighty":-9.134131,"marketCap":5351925560},{"date":"2024-06-21","current":-11.51586,"twenty":-11.394726,"median":-9.834343,"eighty":-9.179147,"marketCap":6284626280},{"date":"2024-06-28","current":-7.449742,"twenty":-11.394726,"median":-9.882424,"eighty":-9.134131,"marketCap":4063910280},{"date":"2024-07-05","current":-8.013266,"twenty":-11.3835,"median":-9.736726,"eighty":-9.096784,"marketCap":4370369088},{"date":"2024-07-12","current":-8.782148,"twenty":-11.375713,"median":-9.612459,"eighty":-8.973485,"marketCap":4796746560},{"date":"2024-07-19","current":-8.033889,"twenty":-11.260937,"median":-9.536435,"eighty":-8.759388,"marketCap":4388134816},{"date":"2024-07-26","current":-8.627957,"twenty":-11.24224,"median":-9.513744,"eighty":-8.627957,"marketCap":4730125080},{"date":"2024-08-02","current":-9.119354,"twenty":-11.155317,"median":-9.51436,"eighty":-8.659337,"marketCap":4996611000},{"date":"2024-08-09","current":-9.602516,"twenty":-11.096166,"median":-9.502501,"eighty":-8.759388,"marketCap":5296407660},{"date":"2024-08-16","current":-9.659156,"twenty":-11.082764,"median":-9.523303,"eighty":-8.782148,"marketCap":5329718400},{"date":"2024-08-23","current":-11.457751,"twenty":-11.24224,"median":-9.560506,"eighty":-8.785621,"marketCap":5274200500},{"date":"2024-08-30","current":-11.261539,"twenty":-11.260937,"median":-9.602516,"eighty":-8.853804,"marketCap":5218682600},{"date":"2024-09-06","current":-12.381731,"twenty":-11.301814,"median":-9.616314,"eighty":-8.872714,"marketCap":5740550860},{"date":"2024-09-13","current":-12.966504,"twenty":-11.41285,"median":-9.666597,"eighty":-8.919616,"marketCap":5995933200},{"date":"2024-09-20","current":-13.175636,"twenty":-11.495182,"median":-9.727036,"eighty":-8.943786,"marketCap":6129176160},{"date":"2024-09-27","current":-11.412309,"twenty":-11.503472,"median":-9.834343,"eighty":-8.968754,"marketCap":5340821980},{"date":"2024-10-04","current":-10.630177,"twenty":-11.500266,"median":-9.955419,"eighty":-8.992959,"marketCap":4952196680},{"date":"2024-10-10","current":-9.640046,"twenty":-11.496891,"median":-9.984689,"eighty":-9.012278,"marketCap":4463639160},{"date":"2024-10-18","current":-7.823087,"twenty":-11.483911,"median":-9.882424,"eighty":-8.891475,"marketCap":3602001352},{"date":"2024-10-25","current":-6.637022,"twenty":-11.464072,"median":-9.731881,"eighty":-8.768492,"marketCap":3055705216},{"date":"2024-11-01","current":-6.266219,"twenty":-11.439791,"median":-9.666597,"eighty":-8.552796,"marketCap":2886930800},{"date":"2024-11-08","current":-6.11978,"twenty":-11.412634,"median":-9.628889,"eighty":-8.354641,"marketCap":2798102160},{"date":"2024-11-15","current":-4.903744,"twenty":-11.406399,"median":-9.610023,"eighty":-8.146037,"marketCap":2225157432},{"date":"2024-11-22","current":-4.446271,"twenty":-11.39192,"median":-9.574881,"eighty":-7.917147,"marketCap":2016410128},{"date":"2024-11-29","current":-5.262129,"twenty":-11.380385,"median":-9.536435,"eighty":-7.700796,"marketCap":2385048984},{"date":"2024-12-06","current":-5.795133,"twenty":-11.346153,"median":-9.513744,"eighty":-7.24659,"marketCap":2620444880},{"date":"2024-12-13","current":-4.23234,"twenty":-11.292835,"median":-9.462151,"eighty":-6.614509,"marketCap":1912036476},{"date":"2024-12-20","current":-3.65763,"twenty":-11.272236,"median":-9.353096,"eighty":-6.423955,"marketCap":1643329840},{"date":"2024-12-27","current":-3.704989,"twenty":-11.261539,"median":-9.289241,"eighty":-6.377951,"marketCap":1663316284},{"date":"2025-01-03","current":-3.459219,"twenty":-11.261057,"median":-9.234052,"eighty":-6.353973,"marketCap":1554501200},{"date":"2025-01-10","current":-3.422771,"twenty":-11.250301,"median":-9.146052,"eighty":-6.232964,"marketCap":1532294040},{"date":"2025-01-17","current":-3.325837,"twenty":-11.24332,"median":-9.119354,"eighty":-5.607796,"marketCap":1490100436},{"date":"2025-01-24","current":-3.940539,"twenty":-11.188065,"median":-9.092192,"eighty":-5.378133,"marketCap":1776572800},{"date":"2025-01-28","current":-4.706176,"twenty":-11.17068,"median":-9.087355,"eighty":-5.266211,"marketCap":2131887360},{"date":"2025-02-07","current":-3.301677,"twenty":-11.154739,"median":-9.066381,"eighty":-4.958001,"marketCap":1487879720},{"date":"2025-02-14","current":-3.418254,"twenty":-11.143754,"median":-8.989713,"eighty":-4.539173,"marketCap":1536735472},{"date":"2025-02-21","current":-3.43891,"twenty":-11.106485,"median":-8.919616,"eighty":-4.354459,"marketCap":1554501200},{"date":"2025-02-28","current":-3.351703,"twenty":-11.093486,"median":-8.819713,"eighty":-4.122814,"marketCap":1510086880},{"date":"2025-03-07","current":-3.387392,"twenty":-11.071174,"median":-8.759388,"eighty":-3.975573,"marketCap":1532294040},{"date":"2025-03-14","current":-5.398225,"twenty":-11.023325,"median":-8.622598,"eighty":-3.975573,"marketCap":2442787600},{"date":"2025-03-21","current":-4.408646,"twenty":-11.005989,"median":-8.475358,"eighty":-3.996365,"marketCap":1994202968},{"date":"2025-03-28","current":-4.427424,"twenty":-10.958538,"median":-8.354936,"eighty":-4.069456,"marketCap":1998644400},{"date":"2025-04-03","current":-5.532239,"twenty":-10.950727,"median":-8.251895,"eighty":-4.071454,"marketCap":1987540820},{"date":"2025-04-11","current":-5.176788,"twenty":-10.949179,"median":-8.134698,"eighty":-4.113712,"marketCap":1843194280},{"date":"2025-04-17","current":-5.605956,"twenty":-10.931954,"median":-8.013266,"eighty":-4.15012,"marketCap":1998644400},{"date":"2025-04-25","current":-6.813611,"twenty":-10.860673,"median":-7.855635,"eighty":-4.203093,"marketCap":2433904736},{"date":"2025-05-02","current":-6.97286,"twenty":-10.741685,"median":-7.823087,"eighty":-4.240312,"marketCap":2496084784},{"date":"2025-05-09","current":-6.850326,"twenty":-10.62989,"median":-7.688151,"eighty":-4.256936,"marketCap":2469436192},{"date":"2025-05-16","current":-6.660384,"twenty":-10.625613,"median":-7.362552,"eighty":-4.28571,"marketCap":2420580440},{"date":"2025-05-23","current":-6.920763,"twenty":-10.596701,"median":-7.188701,"eighty":-4.327055,"marketCap":2522733376},{"date":"2025-05-30","current":-6.975387,"twenty":-10.531077,"median":-7.035719,"eighty":-4.335168,"marketCap":2553823400},{"date":"2025-06-06","current":-8.954176,"twenty":-10.530643,"median":-7.056435,"eighty":-4.354459,"marketCap":3286659680},{"date":"2025-06-13","current":-10.1118,"twenty":-10.525842,"median":-7.245424,"eighty":-4.362058,"marketCap":3713037152},{"date":"2025-06-20","current":-9.295434,"twenty":-10.49786,"median":-7.449742,"eighty":-4.377592,"marketCap":3406578344},{"date":"2025-06-27","current":-9.088195,"twenty":-10.44408,"median":-7.654473,"eighty":-4.399074,"marketCap":3339956864},{"date":"2025-07-04","current":-9.256954,"twenty":-10.441448,"median":-7.771425,"eighty":-4.408646,"marketCap":3402136912},{"date":"2025-07-11","current":-9.278386,"twenty":-10.438605,"median":-7.855635,"eighty":-4.408983,"marketCap":3406578344},{"date":"2025-07-18","current":-10.375245,"twenty":-10.375245,"median":-8.023578,"eighty":-4.415927,"marketCap":3806307224},{"date":"2025-07-25","current":-11.242346,"twenty":-10.444738,"median":-8.163045,"eighty":-4.427424,"marketCap":4139414624},{"date":"2025-08-01","current":-12.956889,"twenty":-10.531115,"median":-8.317696,"eighty":-4.446271,"marketCap":4741228660},{"date":"2025-08-08","current":-12.531071,"twenty":-10.816023,"median":-8.356409,"eighty":-4.497422,"marketCap":4596882120},{"date":"2025-08-15","current":-13.616918,"twenty":-10.950727,"median":-8.486422,"eighty":-4.706176,"marketCap":4987728136},{"date":"2025-08-22","current":-28.922954,"twenty":-11.024815,"median":-8.611071,"eighty":-4.860396,"marketCap":6035906088},{"date":"2025-08-29","current":-26.076607,"twenty":-11.152426,"median":-8.643647,"eighty":-4.89511,"marketCap":5467884128},{"date":"2025-09-05","current":-27.424941,"twenty":-11.24224,"median":-8.759388,"eighty":-4.895913,"marketCap":5744911480},{"date":"2025-09-12","current":-33.976118,"twenty":-11.261539,"median":-8.783884,"eighty":-4.903744,"marketCap":7130048240},{"date":"2025-09-19","current":-32.137812,"twenty":-11.3835,"median":-8.872714,"eighty":-4.920955,"marketCap":6739485088},{"date":"2025-09-26","current":-31.917438,"twenty":-11.446602,"median":-8.942813,"eighty":-4.93749,"marketCap":6675905040},{"date":"2025-10-03","current":-36.693474,"twenty":-11.494681,"median":-8.957754,"eighty":-4.939756,"marketCap":7693185808},{"date":"2025-10-10","current":-31.866218,"twenty":-11.50418,"median":-8.989713,"eighty":-4.971797,"marketCap":6671363608},{"date":"2025-10-17","current":-31.02267,"twenty":-11.536491,"median":-9.052042,"eighty":-5.060821,"marketCap":6489706328},{"date":"2025-10-24","current":-25.824743,"twenty":-11.67702,"median":-9.080681,"eighty":-5.119056,"marketCap":5404304080},{"date":"2025-10-31","current":-23.597698,"twenty":-11.854109,"median":-9.087898,"eighty":-5.129572,"marketCap":4945619448},{"date":"2025-11-07","current":-20.869587,"twenty":-12.197299,"median":-9.096784,"eighty":-5.138538,"marketCap":4371128300},{"date":"2025-11-14","current":-22.685433,"twenty":-12.458841,"median":-9.113568,"eighty":-5.155799,"marketCap":4764920384},{"date":"2025-11-21","current":-21.57415,"twenty":-12.521958,"median":-9.126184,"eighty":-5.17154,"marketCap":4529392000},{"date":"2025-11-28","current":-24.204574,"twenty":-12.94929,"median":-9.16505,"eighty":-5.177501,"marketCap":5100095392},{"date":"2025-12-05","current":-22.466634,"twenty":-13.164946,"median":-9.191702,"eighty":-5.178705,"marketCap":4742036512},{"date":"2025-12-12","current":-22.1097,"twenty":-13.511538,"median":-9.209948,"eighty":-5.212195,"marketCap":4675330264},{"date":"2025-12-19","current":-20.041803,"twenty":-17.63398,"median":-9.232059,"eighty":-5.270292,"marketCap":4248039442},{"date":"2025-12-24","current":-19.36285,"twenty":-19.558586,"median":-9.239461,"eighty":-5.282537,"marketCap":4116913158},{"date":"2026-01-02","current":-20.737965,"twenty":-19.704926,"median":-9.253177,"eighty":-5.315175,"marketCap":4426642484},{"date":"2026-01-09","current":-23.204245,"twenty":-20.357213,"median":-9.278386,"eighty":-5.378549,"marketCap":4965417516},{"date":"2026-01-16","current":-24.098803,"twenty":-20.760618,"median":-9.31719,"eighty":-5.397051,"marketCap":5173599760},{"date":"2026-01-23","current":-22.922252,"twenty":-21.536475,"median":-9.368149,"eighty":-5.401271,"marketCap":4916293200},{"date":"2026-01-30","current":-21.794057,"twenty":-21.687913,"median":-9.424295,"eighty":-5.425026,"marketCap":4695690300},{"date":"2026-02-06","current":-20.334967,"twenty":-21.659361,"median":-9.513128,"eighty":-5.511946,"marketCap":4392431440},{"date":"2026-02-13","current":-21.335749,"twenty":-21.659361,"median":-9.528371,"eighty":-5.55032,"marketCap":4635075264},{"date":"2026-02-20","current":-20.973148,"twenty":-21.649543,"median":-9.534937,"eighty":-5.562312,"marketCap":4549739576},{"date":"2026-02-27","current":-17.376769,"twenty":-21.609505,"median":-9.566812,"eighty":-5.593401,"marketCap":3810912172},{"date":"2026-03-06","current":-17.920587,"twenty":-21.564731,"median":-9.594832,"eighty":-5.599011,"marketCap":3898493536},{"date":"2026-03-13","current":-18.300829,"twenty":-21.488875,"median":-9.614895,"eighty":-5.602974,"marketCap":3999548956},{"date":"2026-03-20","current":-18.380704,"twenty":-21.336069,"median":-9.649601,"eighty":-5.606602,"marketCap":4001794632},{"date":"2026-03-27","current":-20.040776,"twenty":-21.318389,"median":-9.681606,"eighty":-5.612646,"marketCap":4352120088},{"date":"2026-04-02","current":12.478766,"twenty":-21.24895,"median":-9.659156,"eighty":-5.598207,"marketCap":4464403888},{"date":"2026-04-10","current":12.781914,"twenty":-21.241413,"median":-9.628889,"eighty":-5.5458,"marketCap":4608127152},{"date":"2026-04-17","current":12.751644,"twenty":-21.234144,"median":-9.610023,"eighty":-5.395876,"marketCap":4599144448},{"date":"2026-04-24","current":11.21309,"twenty":-21.216401,"median":-9.58505,"eighty":-5.228839,"marketCap":4044462476},{"date":"2026-04-30","current":10.7021,"twenty":-21.203518,"median":-9.560506,"eighty":-5.17154,"marketCap":3862562720},{"date":"2026-05-08","current":10.358859,"twenty":-21.109524,"median":-9.533439,"eighty":-5.114765,"marketCap":3750278920},{"date":"2026-05-15","current":10.61627,"twenty":-20.963352,"median":-9.513744,"eighty":-4.927569,"marketCap":3853580016},{"date":"2026-05-22","current":9.629856,"twenty":-20.934581,"median":-9.462151,"eighty":-4.874282,"marketCap":3487534828},{"date":"2026-05-29","current":10.418336,"twenty":-20.904691,"median":-9.37169,"eighty":-4.456501,"marketCap":3786209736},{"date":"2026-06-05","current":9.397468,"twenty":-20.865916,"median":-9.353096,"eighty":-4.408713,"marketCap":3420164548},{"date":"2026-06-12","current":9.885443,"twenty":-20.842881,"median":-9.289241,"eighty":-4.354459,"marketCap":3595327276},{"date":"2026-06-18","current":8.798669,"twenty":-20.809475,"median":-9.260665,"eighty":-4.275598,"marketCap":3206825328},{"date":"2026-06-26","current":8.4741,"twenty":-20.737965,"median":-9.247135,"eighty":-4.113712,"marketCap":3074330444},{"date":"2026-07-03","current":9.525463,"twenty":-20.637607,"median":-9.233055,"eighty":-3.977556,"marketCap":3458341040},{"date":"2026-07-10","current":9.469045,"twenty":-20.557354,"median":-9.218198,"eighty":-3.819713,"marketCap":3433638604},{"date":"2026-07-17","current":9.867437,"twenty":-20.504561,"median":-9.194332,"eighty":-3.699682,"marketCap":3590835924},{"date":"2026-07-24","current":9.994782,"twenty":-20.472909,"median":-9.165919,"eighty":-3.658551,"marketCap":3637995120},{"date":"2026-07-31","current":9.98398,"twenty":-20.387953,"median":-9.159435,"eighty":-3.646486,"marketCap":3640966860},{"date":"2026-08-07","current":10.600412,"twenty":-20.327675,"median":-9.121996,"eighty":-3.503724,"marketCap":3873273948},{"date":"2026-08-14","current":10.770175,"twenty":-20.154207,"median":-9.100722,"eighty":-3.481151,"marketCap":3940285608},{"date":"2026-08-21","current":5.952896,"twenty":-20.041187,"median":-9.088801,"eighty":-3.461369,"marketCap":3790626234}],"updateTime":1787575559243},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02509\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661825085","title":"自免龙头兑现长期主义：荃信生物（02509）营收翻倍背后的“双引擎”逻辑","url":"https://stock-news.laohu8.com/highlight/detail?id=2661825085","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661825085?lang=zh_cn&edition=fundamental","pubTime":"2026-08-21 14:53","pubTimestamp":1787295187,"startTime":"0","endTime":"0","summary":"在此背景下，专注于自免领域的荃信生物2026年中期交出里程碑答卷，不仅印证了商业化兑现能力，更凸显了其全球化布局的战略成效。从核心财务数据来看，荃信生物在2026年上半年展现出强劲的增长势能。在智通财经APP看来，商业化基本盘的稳固与爆发，是支撑荃信生物业绩高增的关键引擎。在稳固国内基本盘的同时，荃信生物的出海合作项目也正迎来密集兑现期。展望未来，荃信生物的管线梯队正加速走向收获期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483182.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"自免龙头兑现长期主义：荃信生物（02509）营收翻倍背后的“双引擎”逻辑","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660426865","title":"荃信生物-B(02509)发布中期业绩 股东应占溢利2.03亿元 同比扭亏为盈 “荃信1.0”布局已基本成型","url":"https://stock-news.laohu8.com/highlight/detail?id=2660426865","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660426865?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 21:29","pubTimestamp":1787146189,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B 发布截至2026年6月30日止6个月业绩，该集团期内取得收入4.24亿元人民币，同比增加105.37%;公司权益股东应占溢利2.03亿元，同比扭亏为盈;每股基本盈利0.91元。收入增加主要由于授权收入及QX001S利润分成增加所致。随着前述单抗产品在商业端和研发端的持续兑现，“荃信1.0”布局已基本成型。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1482241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120262738","title":"荃信生物-B（02509）2026年中期收入4.24亿元 由亏转盈录得1.99亿元净利润","url":"https://stock-news.laohu8.com/highlight/detail?id=1120262738","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120262738?lang=zh_cn&edition=fundamental","pubTime":"2026-08-19 21:26","pubTimestamp":1787145998,"startTime":"0","endTime":"0","summary":"2026年8月19日，荃信生物-B公布截至2026年6月30日止六个月未经审计中期业绩。期内，公司实现收入4.24亿元，同比增幅105.4%。授权收入3.79亿元，其中包括QX027N海外授权首付款及非现金对价、QX008N及QX031N里程碑款，以及QX001S合作协议利润分成收入40.4百万元；QX001S产品供应收入9.2百万元。销售成本为5,272.4万元，同比增加82.8%，主要受海外授权项目及CDMO服务成本增长影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108795750","title":"荃信生物-B（02509）拟于8月19日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1108795750","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108795750?lang=zh_cn&edition=fundamental","pubTime":"2026-08-07 16:36","pubTimestamp":1786091801,"startTime":"0","endTime":"0","summary":"江苏荃信生物医药股份有限公司（02509，以下简称“荃信生物-B”）8月7日公告称，公司董事会决定于2026年8月19日（星期三）召开会议，届时将审议并批准本集团截至2026年6月30日止六个月的中期业绩及其发布事宜，并处理其他相关事项。\n公告显示，截至公告日，公司董事会成员包括：董事会主席兼执行董事裘霽宛先生，执行董事吴亦亮先生及林伟栋先生；非执行董事余熹先生及吴志强先生；独立非执行董事冯志伟先生、邹忠梅博士及凌建群博士。\n公司表示，香港交易及结算所有限公司及香港联合交易所有限公司对本公告内容概不负责，并不对其准确性或完整性作出任何声明，也不承担因依赖该公告内容而引致的任何损失责任。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166349659","title":"荃信生物-B发布7月股份变动月报，股本维持227,071,600元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166349659","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166349659?lang=zh_cn&edition=fundamental","pubTime":"2026-08-06 16:00","pubTimestamp":1786003254,"startTime":"0","endTime":"0","summary":"荃信生物-B于2026年8月6日披露了截至2026年7月31日止的月度证券变动报告。公告显示，公司法定注册股本维持227,071,600元，与上月末一致。本月内，荃信生物-B普通股H股已发行股份由上月底结存的223,381,800股下降至223,369,200股，减少12,600股；同时公司库存股份增加12,600股，从3,689,800股升至3,702,400股。公司确认上述变动后已发行股份总数继续维持在227,071,600股不变。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656143344","title":"荃信生物(02509.HK)QX027N获慢性阻塞性肺疾病及慢性鼻窦炎伴鼻息肉适应症临床试验默示许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2656143344","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656143344?lang=zh_cn&edition=fundamental","pubTime":"2026-08-03 10:19","pubTimestamp":1785723540,"startTime":"0","endTime":"0","summary":"荃信生物(02509.HK) 公布，近期，公司自主研发的长效双抗QX027N注射液获得中国国家药品监督管理局药品审评中心的临床试验默示许可，分别拟用于治疗慢性阻塞性肺疾病(COPD)及慢性鼻窦炎伴鼻息肉(CRSwNP)。本次获批是QX027N继特应性皮炎(AD)及哮喘后新增的两项呼吸系统相关适应症。(sl/u)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240325152227966_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240325152227966_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1536161/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1536161/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655636655","title":"荃信生物：QX027N注射液两项适应症获临床试验许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2655636655","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655636655?lang=zh_cn&edition=fundamental","pubTime":"2026-07-31 20:01","pubTimestamp":1785499260,"startTime":"0","endTime":"0","summary":"7月31日，荃信生物（02509）发布公告，近日，公司自主研发的长效双抗QX027N注射液获得中国国家药品监督管理局药品审评中心的临床试验默示许可，分别拟用于治疗慢性阻塞性肺疾病及慢性鼻窦炎伴鼻息肉。这次获批是QX027N继特应性皮炎及哮喘后新增的两项呼吸系统相关适应症。公司将加快该候选药物的临床开发节奏，以巩固在相关领域的领先优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607313828550155.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607313828550155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["PSYK","02509","BK1161","IBBJ","IBBQ","MDTX","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199457602","title":"荃信生物-B（02509）长效双抗QX027N获COPD及CRSwNP临床试验默示许可","url":"https://stock-news.laohu8.com/highlight/detail?id=1199457602","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199457602?lang=zh_cn&edition=fundamental","pubTime":"2026-07-31 19:20","pubTimestamp":1785496838,"startTime":"0","endTime":"0","summary":"2026年7月31日，江蘇荃信生物醫藥股份有限公司发布自愿公告称，其自主研发的长效双特异性单克隆抗体QX027N注射液已获得中国国家药品监督管理局药品审评中心临床试验默示许可，拟用于治疗慢性阻塞性肺疾病和慢性鼻窦炎伴鼻息肉，受理号分别为CXSL2600561和CXSL2600560。该项目在特应性皮炎及哮喘之后新增两项呼吸系统相关适应症。公司介绍，该候选药物旨在为哮喘、COPD、AD及CRSwNP等免疫炎症类疾病提供更深层次且更持久的疾病控制。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156603396","title":"荃信生物-B（02509.HK）旗下QX027n获两项临床试验批件，剑指COPD与慢性鼻窦炎","url":"https://stock-news.laohu8.com/highlight/detail?id=1156603396","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156603396?lang=zh_cn&edition=fundamental","pubTime":"2026-07-31 19:18","pubTimestamp":1785496736,"startTime":"0","endTime":"0","summary":"荃信生物-B（QYUNS-B）近日宣布，其研发管线中的核心产品——QX027n，已成功获得两项临床试验批准。这两项批件分别针对慢性阻塞性肺疾病（COPD）以及慢性鼻窦炎两大适应症。\n这一进展标志着该药物在呼吸系统及耳鼻喉领域迈出了关键一步。COPD作为一种常见且严重的肺部疾病，患者群体庞大；而慢性鼻窦炎同样困扰着数以百万计的人群，治疗方案仍有待优化。QX027n若能在此两个领域取得突破，无疑将为患者带来新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655363591","title":"荃信生物-B(02509.HK)：QX027N获得慢性阻塞性肺疾病及慢性鼻窦炎伴鼻息肉两项适应症的临床试验默示许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2655363591","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655363591?lang=zh_cn&edition=fundamental","pubTime":"2026-07-31 19:18","pubTimestamp":1785496712,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655860380","title":"荃信生物-B(02509)合作伙伴Caldera Therapeutics拟与Synlogic合并登陆纳斯达克 并同步募资 2.78 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2655860380","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655860380?lang=zh_cn&edition=fundamental","pubTime":"2026-07-29 20:06","pubTimestamp":1785326788,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B 公布，于2026年7月29日，公司合作伙伴Caldera Therapeutics,Inc与Synlogic,Inc.订立最终合并协议，以进行全股票交易合并。该合并将通过Caldera Therapeutics及Synlogic成为一家新成立的控股公司的全资附属公司而实现。完成后，合并并后的公司将以Caldera Therapeutics,Inc.的名称营运，并预期于纳斯达克资本市场以股票代码“CALD”进行交易。该私募融资仅由CalderaTherapeutics完成。Synlogic股东于拟议合并完成时将拥有的合并后公司所有权百分比将根据Synlogic于紧接完成日期前的估计现金净额进行调整。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1473708.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SYBX","BK1161","02509","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129909769","title":"荃信生物-B：合作方Caldera擬與Synlogic合併赴美上市並獲2.78億美元私募支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1129909769","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129909769?lang=zh_cn&edition=fundamental","pubTime":"2026-07-29 20:00","pubTimestamp":1785326448,"startTime":"0","endTime":"0","summary":"2026年7月29日，荃信生物-B发布自愿公告，披露其合作伙伴Caldera Therapeutics, Inc.已与Synlogic, Inc.签署最终合并协议，双方将通过全股票交易方式合并为新设控股公司的全资子公司。合并完成后，新公司将沿用“Caldera Therapeutics, Inc.”名称，并预计以股票代码“CALD”在纳斯达克资本市场挂牌交易。为配合拟议合并，Caldera Therapeutics已获一批医疗健康机构投资者及共同基金承诺认购，计划在同步私募融资中募集约2.78亿美元。Synlogic股东的最终持股比例将根据交易完成前其估计现金净额进行调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186215746","title":"荃信生物-B回购1000股股份，耗资约1.60万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186215746","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186215746?lang=zh_cn&edition=fundamental","pubTime":"2026-07-17 17:32","pubTimestamp":1784280730,"startTime":"0","endTime":"0","summary":"荃信生物-B于2026年7月17日发布公告，披露公司于香港联交所场内回购1000股普通股H股。该批股份占回购前已发行股本的约0.00045%，每股回购价为每股15.99港元，涉资总额约1.60万港元。本次回购股份将被持作库藏股。公告显示，经本次变动后，公司已发行股份总数仍为227,071,600股，其中在外流通股数为223,369,200股，库藏股数则增至3,702,400股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B回购1000股股份，耗资约1.60万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652401327","title":"荃信生物-B(02509)7月17日耗资约1.6万港元回购1000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652401327","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652401327?lang=zh_cn&edition=fundamental","pubTime":"2026-07-17 17:30","pubTimestamp":1784280616,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)公布，2026年7月17日耗资约1.6万港元回购1000股股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469055.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652936476","title":"荃信生物－Ｂ(02509)股价下跌5.031%，现价港币$15.1","url":"https://stock-news.laohu8.com/highlight/detail?id=2652936476","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652936476?lang=zh_cn&edition=fundamental","pubTime":"2026-07-17 09:50","pubTimestamp":1784253000,"startTime":"0","endTime":"0","summary":"[下跌股]荃信生物－Ｂ(02509) 股价在上午09:49比前收市价下跌5.031%，现股价为港币$15.1。至目前为止，今日最高价为$15.6，而最低价为$15.1。总成交量为1.82万股，总成交金额为港币$28.065万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152747204_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2607171682/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2607171682/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180232421","title":"荃信生物-B回购3,000股，耗资约4.52万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1180232421","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180232421?lang=zh_cn&edition=fundamental","pubTime":"2026-07-09 18:26","pubTimestamp":1783592809,"startTime":"0","endTime":"0","summary":"江苏荃信生物医药股份有限公司于2026年7月9日发布公告，称公司当日通过香港联交所场内回购3,000股H股，占回购前已发行股本的约0.001343%。本次回购价格为每股15.08港元，总耗资约4.52万港元。公告显示，回购完成后，公司已发行股本总数仍为227,071,600股，其中不含库存股份的已发行股本由223,373,200股下降至223,370,200股，库存股份数量由3,698,400股增至3,701,400股。本次回购后，公司在新股发行及库存股份出售或转让方面将适用的暂止期截至2026年8月8日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B回购3,000股，耗资约4.52万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650237739","title":"荃信生物-B(02509)7月9日斥资约4.52万港元回购3000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650237739","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650237739?lang=zh_cn&edition=fundamental","pubTime":"2026-07-09 18:23","pubTimestamp":1783592617,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年7月9日该公司斥资约4.52万港元回购3000股，回购价格为每股15.08港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1465411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650948957","title":"荃信生物－Ｂ(02509)股价下跌5.35%，现价港币$14.86","url":"https://stock-news.laohu8.com/highlight/detail?id=2650948957","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650948957?lang=zh_cn&edition=fundamental","pubTime":"2026-07-09 11:00","pubTimestamp":1783566000,"startTime":"0","endTime":"0","summary":"[下跌股]荃信生物－Ｂ(02509) 股价在上午10:59比前收市价下跌5.35%，现股价为港币$14.86。至目前为止，今日最高价为$14.86，而最低价为$14.86。总成交量为200股，总成交金额为港币$2972。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2607091465/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2607091465/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174667974","title":"荃信生物-B：7月8日回购600股，耗资约9,420港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1174667974","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174667974?lang=zh_cn&edition=fundamental","pubTime":"2026-07-08 18:37","pubTimestamp":1783507076,"startTime":"0","endTime":"0","summary":"荃信生物-B于2026年7月8日根据股份回购授权，在香港联合交易所场内回购600股普通股，约占当日公司现有已发行股本的0.00027%，每股回购价格为15.70港元，合计耗资9,420港元。公告日期为2026年7月8日。本次回购完成后，截至2026年7月8日，荃信生物-B的已发行股本总数仍为227,071,600股，其中流通股数量减少至223,373,200股，库藏股数量增至3,698,400股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B：7月8日回购600股，耗资约9,420港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174266156","title":"荃信生物-B：7月7日回购8000股，耗资约12.56万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1174266156","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174266156?lang=zh_cn&edition=fundamental","pubTime":"2026-07-07 19:02","pubTimestamp":1783422137,"startTime":"0","endTime":"0","summary":"2026年7月7日，江苏荃信生物医药股份有限公司发布翌日报表公告，披露于当日通过香港联交所场内回购普通股（H股）8,000股，占回购前已发行股本约0.0036%。每股回购价为15.70港元，涉资约12.56万港元。截至本次回购后，公司累计根据该授权购回股份数量为989,600股，占授权获通过当日已发行股本总数的0.4411%。公司方面确认已遵守香港联合交易所有限公司证券上市规则的相关规定。本次公告由董事会秘书和联席公司秘书胡衍保签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"荃信生物-B：7月7日回购8000股，耗资约12.56万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":104,"code":"91000000","status":"200"}]}}